Patents by Inventor Virginie Sauvage

Virginie Sauvage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9403880
    Abstract: The present invention relates to HGyV, a human gyrovirus related to the chicken anemia virus (CAV). The present invention also relates to a new proteins encoded by HGyV, which proteins display some homology to CAV proteins. Among these new proteins, H-apoptin is of particular interest as it is herein found for the first time in a human virus and can be used for treating cancer. Also provided are methods for detecting the HGyV virus in a subject.
    Type: Grant
    Filed: November 25, 2011
    Date of Patent: August 2, 2016
    Assignees: INSTITUT PASTEUR, ECOLE NATIONALE VETERINAIRE D'ALFORT, PATHOQUEST
    Inventors: Marc Eloit, Justine Cheval, Virginie Sauvage
  • Publication number: 20140024017
    Abstract: The invention relates to the identification of a novel human polyomavirus species (designated IPPyV) and applications derived from the identified features and properties of this virus. The IPPy virus species of the invention qualifies as a human virus, in view of the fact that it is capable of infecting a human host. Having identified a novel human polyomavirus species, IPPyV, the inventors have been able to propose means for the detection of exposure or infection by such a virus, especially detection in a biological sample previously obtained from a human host. The invention also concerns means suitable for obtaining an immune response in a host with a view to prevent the onset or the development of an infection with an IPPyV.
    Type: Application
    Filed: December 27, 2011
    Publication date: January 23, 2014
    Inventors: Marc Eloit, Justine Cheval, Virginie Sauvage
  • Publication number: 20130345400
    Abstract: The present invention relates to HGyV, a human gyrovirus related to the chicken anemia virus (CAV). The present invention also relates to a new proteins encoded by HGyV, which proteins display some homology to CAV proteins. Among these new proteins, H-apoptin is of particular interest as it is herein found for the first time in a human virus and can be used for treating cancer. Also provided are methods for detecting the HGyV virus in a subject.
    Type: Application
    Filed: November 25, 2011
    Publication date: December 26, 2013
    Applicants: INSTITUT PASTEUR, PATHOQUEST, ECOLE NATIONALE VETERINAIRE D'ALFORT
    Inventors: Marc Eloit, Justine Cheval, Virginie Sauvage, Vincent Foulongne